Biospecimen Quality For Precision Medicine
September 27, 2018
CloudLIMS hosted a complimentary webinar on “Biospecimen Quality For Precision Medicine” and received an overwhelming response. A large number of attendees attended the live webinar. The webinar was presented by Dr. Jim Vaught, Editor-in-Chief of Biopreservation and Biobanking (BIO), the official journal of ISBER. We received several interesting questions from the attendees and it was a great experience interacting with them.
Precision medicine has the potential to significantly improve patient care by providing personalized treatments to patients. Human biospecimens are integral for precision medicine research, which aims at developing personalized medicine based on an individual's genetic makeup, environment, demographic factors, and lifestyle. High-quality, properly annotated, legally and ethically acquired biospecimens are indispensable for effective precision medicine research. Biobanks not only provide human biospecimens such as tissue, blood, and other bodily fluids to researchers but also provide associated clinical and molecular metadata, which is crucial for biomedical research, drug discovery, and precision medicine advancement.
The webinar focused on the role of biobanks in precision medicine, the challenges faced by precision medicine, the factors researchers should consider when sourcing biospecimens from biobanks, and the key elements of maintaining biospecimen quality. The webinar also highlighted the significance of a cloud-based biobanking LIMS in minimizing operational costs, thus improving the financial sustainability of biobanks.
If you missed the chance to attend the webinar, you can watch the video. If you would like to discuss some of the biobanking data management and regulatory challenges you face, you can sign up to talk to our experts.
Also, watch the webinar: Role of Biobanks: Challenges and Opportunities in Cancer Research.